These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 89745)

  • 1. Pharmacological models for characterizing new anti-asthmatics.
    Kumagai A; Tomioka H
    Triangle; 1978; 17(3-4):135-40. PubMed ID: 89745
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug, HC 20-511 (ketotifen).
    Tomioka H; Yoshida S; Tanaka M; Kumagai A
    Monogr Allergy; 1979; 14():313-7. PubMed ID: 91958
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketotifen: a histamine release inhibitor.
    Martin U; Roemer D
    Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of BL-5255Z, an antiallergy compound that blocks SRS activity.
    Gillespie E; Dungan KW
    Monogr Allergy; 1983; 18():211-9. PubMed ID: 6196627
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments.
    Takahashi K; Yamada N; Endoh K; Yasumura K
    Arerugi; 1986 Sep; 35(9):982-7. PubMed ID: 2432858
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.
    Martin U; Römer D
    Arzneimittelforschung; 1978; 28(5):770-82. PubMed ID: 35171
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of allergen-mediated histamine release from human cells by ketotifen and oxatomide. Comparison with other H1 antihistamines.
    Radermecker M
    Respiration; 1981; 41(1):45-55. PubMed ID: 6166035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ketotifene: experimental and clinical data].
    Craps L
    Schweiz Med Wochenschr; 1980 Feb; 110(6):187-91. PubMed ID: 6769157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modulation of mediator release: therapeutic significance?
    Hegardt B
    Eur J Respir Dis Suppl; 1983; 129():112-47. PubMed ID: 6197316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ketotifen and platelet aggregation: in vitro studies].
    Somma A; Cantone F; Campidonico U; Mazzeo V; Visone C; Scognamiglio A; Alise G
    Boll Chim Farm; 1980 Nov; 119(11):659-62. PubMed ID: 6112010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ketotifen, a selective histamine liberator].
    Gushchin IS; Deriugin IL
    Biull Eksp Biol Med; 1979 Nov; 88(11):597-9. PubMed ID: 94270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Release of histamine and slow reacting substance from leukocytes of asthmatic children stimulated by calcium ionophore A23187 and zymosan activated serum].
    Katagiri M; Kishimoto M; Hida Y; Ueda M; Torii S
    Arerugi; 1986 Sep; 35(9):936-44. PubMed ID: 2432856
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition by azatadine of the immunological release of leukotrienes and histamine from human lung fragments.
    Daniels C; Temple DM
    Eur J Pharmacol; 1986 Apr; 123(3):463-5. PubMed ID: 2424773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central action of histamine. 3. The effect of antazoline and thenalidine on the brain noradrenaline and 5-hydroxytryptamine levels and behavior of rats receiving histamine intraventricularly.
    Kleinrok Z; Jagiello-Wójtowicz E; Kolasa K
    Pol J Pharmacol Pharm; 1973; 25(6):519-24. PubMed ID: 4151860
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs used in allergic states and their mode of action.
    Eisner JW
    Semin Drug Treat; 1973; 2(4):367-77. PubMed ID: 4122217
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of two new histamine antagonists (BM 15,100 and BM 06,001) on bronchial muscle and histamine release from leucocytes.
    Assem ES; Chong EK
    Monogr Allergy; 1979; 14():310-2. PubMed ID: 91957
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
    Zimmermann I; Roesch A; Ulmer WT
    Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The rebirth of the H1-antagonists].
    Sabbah A
    Allerg Immunol (Paris); 1992 Jun; 24(6):224-30. PubMed ID: 1379813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
    Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.